Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2008Journal of Clinical MicrobiologyOpen Access

Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological Perspective

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDaniel CurcioPfizer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Daniel Curcio (2008) studied this question.

synapsesocial.com/papers/6a6fb021f44fa9f079dd2918https://doi.org/10.1128/jcm.02494-07
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment with Tigecycline of Recurrent Urosepsis Caused by Extended-Spectrum-β-Lactamase-Producing <i>Escherichia coli</i>2007 · 31 citations
  2. 2Rapid Development of <i>Acinetobacter baumannii</i> Resistance to Tigecycline2007 · 116 citations
  3. 3Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Tigecycline2005 · 72 citations